CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma.

Oncology (Williston Park, N.Y.)

Volumn 24, Issue 14, 2010, Pages

  Tarhini, Ahmad A ^a   Kirkwood, John M ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

HUMAN; IMMUNOTHERAPY; MELANOMA; MORTALITY; NOTE; PHASE 3 CLINICAL TRIAL (TOPIC);

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; IMMUNOTHERAPY; MELANOMA;

EID: 79952272922     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)